BioAsia 2026: Hyderabad to Host Premier Life Sciences and Healthcare Conclave
The 23rd edition of BioAsia, recognized as Asia's leading life sciences and healthcare conclave, is scheduled to take place in Hyderabad on February 17 and 18, 2026. This significant event is poised to assemble an impressive array of global scientific leaders, pioneering artificial intelligence experts, chief executives from the pharmaceutical and biotechnology sectors, and influential policymakers from around the world.
Theme and Focus Areas
Organized under the compelling theme "TechBio Unleashed: AI, Automation & the Biology Revolution", the conference will delve deeply into the transformative convergence of artificial intelligence, advanced biological sciences, and intelligent manufacturing processes. The primary objective is to examine how these powerful forces are collectively reshaping the entire lifecycle of therapeutic development—from initial discovery and research through to scalable manufacturing and global delivery of treatments.
Strategic Timing and Government Inauguration
BioAsia 2026 is strategically timed, occurring less than one month after the Telangana government unveiled its ambitious new life sciences policy for 2026–30 at the prestigious World Economic Forum in Davos. The conference will be formally inaugurated by Telangana Chief Minister A. Revanth Reddy alongside Industries and IT Minister D. Sridhar Babu, highlighting the state's strong commitment to this sector.
Hyderabad's Global Ambitions
The event aligns perfectly with the Telangana government's active efforts to position Hyderabad among the top five global life sciences hubs. A dedicated session titled "Telangana Rising Vision 2047" will outline the state's comprehensive roadmap for achieving innovation-led growth. This vision encompasses advanced therapeutic modalities, AI-enabled research and development, and next-generation biomanufacturing capabilities.
Distinguished Speaker Lineup
The conference boasts an exceptional roster of international experts. Notable speakers include:
- Dr. Stefan Miltenyi, Founder and President of Miltenyi Biotec, who will address next-generation biologics from discovery through scalable chemistry, manufacturing, and controls.
- Dr. Howard Y. Chang, Chief Scientific Officer at Amgen, presenting on AI-powered biology for target discovery and precision medicine.
- Pushmeet Kohli, Vice President of Science at Google DeepMind, discussing foundational models and protein science breakthroughs accelerating biomedical discovery.
Day Two Highlights and Broader Discussions
The second day will feature a plenary address by Madeleine Roach, Executive Vice President and Head of Business Operations at Sanofi, focusing on the company's AI-first transformation across research, development, and manufacturing. Day two will also spotlight the rising importance of life sciences global capability centers in India, examining their role as innovation engines with significant direct impact on patient outcomes worldwide.
Additional prominent speakers confirmed for the event include:
- Anton Groom, Chief AI Officer at MSD
- Despina Solomonidou, EVP and Global Head of Technical R&D at Novartis
- Rashmi Kumar, SVP and CIO at Medtronic
- Eamonn Warren, Group Vice President of Manufacturing at Eli Lilly
- Badhri Srinivasan, Group CEO of Unilabs
Comprehensive Conference Agenda
Across nine specialized sessions and a marquee CEO Conclave, discussions will comprehensively address critical industry topics. These include scaling innovation across science, software, and supply chains; analyzing sector headwinds and growth drivers through 2030; exploring advanced therapeutic modalities; and examining AI's expanding role across contract research, development, manufacturing, and biomanufacturing operations. BioAsia 2026 is set to be a landmark event driving forward the global life sciences agenda.
